CD4 and COVID-19: HIV-infected patients on ART with a moderately low recently recorded CD4 count (<350 cells/μL) attending an HIV clinic in an informal setting outside Cape Town, South Africa, were recruited to this study after the first COVID-19 wave and during the second and beginning of the third wave.